Frequently Asked Questions

The age range for EVO ICL™ is determined by the FDA based on clinical trials and studies. Patients who are between the ages of 21 and 45 are typically good candidates for this procedure because their eyes have finished developing, and their prescription has stabilized.1 However, age is not the only factor that is considered when determining whether someone is a good candidate for EVO ICL™. Other factors, such as the health of the patient's eyes and the severity of their refractive error, will also be taken into account.

It is worth noting that doctors may choose to implant lenses outside of the approved age range at their discretion, known as "off-label" use. This decision is generally made on a case-by-case basis and depends upon the patient's individual circumstances and eyes. It is important to discuss the risks and benefits of the EVO ICL™ procedure with your eye doctor, who can help determine if you are a good candidate for the procedure based on your unique situation. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center can help determine if the EVO ICL™ is right for you.

1. FDA Patient Information Booklet. Facts you need to know about Staar Surgical's EVO ICL™ and EVO TICL™

The EVO ICL™ is the most advanced and latest version of the tried-and-true Visian ICL. The Visian ICL has been used for over 15 years and more than 400,000 procedures have been performed with great success. The EVO ICL builds on that success by further improving the design of the lens.

Although the EVO ICL™ has received FDA approval in 202219, the lens has been in use outside of the United States for more than 10 years, and over 2,000,000 ICL’s have been implanted worldwide. The EVO ICL™ builds on the success of the Visian ICL, which has been used for over 15 years and has had a high success rate with over 400,000 procedures performed.

The EVO ICL™ is made from a highly biocompatible material known as collamer, which is a proprietary material that provides excellent optical clarity and is well-tolerated by the eye. The EVO ICL™ has an innovative design that allows for better fitting and alignment within the eye, resulting in improved vision outcomes. Additionally, the EVO ICL™ has a central port that allows for better fluid flow, which reduces the risk of cataract formation and provides better long-term results.

In summary, while the EVO ICL™ is a new lens in the United States, it has been used successfully for over 10 years worldwide and builds upon the success of the Visian ICL. The EVO ICL™'s advanced design and use of highly biocompatible materials make it an excellent option for patients seeking vision correction surgery. To determine if the EVO ICL™ is right for you, it is important to consult with a highly experienced EVO ICL™ ophthalmologist, such as Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center.

1. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035

Yes, it is often possible, but not often necessary. If you have a small residual prescription or your vision changes over time, and your corneal thickness and eye health indicate it is safe, you may be able to have a second surgery like LASIK to fine-tune your vision. Fortunately, this is not commonly needed as the success rate with the EVO implantable collamer lens is quite high.

It is important to note that the decision to have LASIK after an EVO ICL™ implantation is dependent on individual circumstances and you should have a complete eye examination. In some cases, LASIK may not be the best option, and other options such as PRK may be considered instead. Additionally, the timing of a LASIK procedure after EVO ICL™ implantation is also an important factor to consider, as the eyes need time to fully heal and stabilize after the initial surgery.

Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center have extensive experience in both EVO ICL™ implantation and LASIK procedures. They can help determine whether LASIK is a viable option for your eyes, and provide guidance on the best timing for the procedure. It is important to follow post-operative instructions closely to ensure proper healing and minimize the risk of complications.

There are always risks associated with any kind of surgery, and like LASIK, the EVO ICL™ is no exception. However, the EVO ICL™ implantable collamer lens procedure is considered a very safe procedure with a low risk of complications.1,4 Some potential risks associated with the EVO ICL™ include glare, halos or double vision, cataracts, increased intraocular pressure, loss of best corrected visual acuity as well as a need for a second surgery, risk of infection or inflammation.16 However, these risks are generally low and can be minimized with proper preoperative evaluation and postoperative care.

Comparatively, LASIK surgery also has a low risk of complications but the specific risks may differ. LASIK carries a slightly higher risk of post-operative dry eyes and the corneal flap created during the surgery may lead to complications, although such issues are rare.2,3,5,6

Ultimately, the choice of which procedure to undergo depends on each individual patient's eyes, lifestyle and health. It is important to have a thorough consultation with an experienced surgeon like Dr. Sandy T. Feldman at Clearview Eye and Laser Medical Center to determine which procedure is right for you and what risks, if any, may be involved for you.

1. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
2. "Is LASIK Safe? What You Need to Know." Refractive Surgery Council, 13 Oct. 2022, https://americanrefractivesurgerycouncil.org/is-lasik-safe/.
3. Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmol. 2017;135(1):13-22.
doi:10.1001/jamaophthalmol.2016.4587. Available: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2587831. Accessed March 1, 2021.
4. FDA Patient Information Booklet. Facts you need to know about Staar Surgical's EVO ICL™ and EVO TICL™
5. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
6. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

This is a difficult question to answer as it depends on each individual patient's eyes, lifestyle and health. The most important question is which procedure is best for YOU. Both the EVO ICL™ and LASIK are very effective methods of vision correction surgery and have a high success rate of achieving spectacle independence.

It is important to note that EVO ICL™ and LASIK are different procedures that correct nearsightedness with or without astigmatism. LASIK corrects vision by reshaping the cornea, while EVO ICL™ involves implanting a lens in the eye. EVO ICL™ is often a better option for patients with very high prescriptions, thin corneas or dry eyes, whereas LASIK may be a better option for patients with moderate to high prescriptions and good corneal thickness.

While LASIK is a more well-known procedure and results of wavefront guided [iDesign LASIK] achieve 20/20 or better vision in more than 95% of patients1, the EVO ICL™ has been shown to have advantages over LASIK in certain cases. For example, a study published in the Journal of Refractive Surgery found that EVO ICL™ provided better visual acuity and contrast sensitivity in patients with high myopia compared to LASIK. Additionally, EVO ICL™ may be a better option for patients who are not suitable candidates for LASIK due to thin corneas or other factors.2

Both procedures have a high patient satisfaction rate, 96% for LASIK and 99.4% of the EVO ICL™.3-5

While LASIK is a more well-known procedure, EVO ICL™ has been shown to have advantages over LASIK in certain cases. For example, a study published found that EVO ICL™ provided better visual acuity and contrast sensitivity in patients with high myopia compared to LASIK.6 Additionally, EVO ICL™ may be a better option for patients who are not suitable candidates for LASIK due to thin corneas, higher prescriptions or other factors.

Ultimately, the decision between EVO ICL™ and LASIK should be based on a thorough consultation with a qualified ophthalmologist like Dr. Sandy T. Feldman. She has significant experience in most advanced forms of surgical vision correction available. and can evaluate your eyes and discuss the advantages and disadvantages of each procedure in order to help you make an informed decision about the best way to achieve clear, sharp vision.

1. Manche E, Lu L. A prospective randomized, fellow eye study comparing wavefront guided and topography guided LASIK surgery. Presentation ASCRS annual meeting 2023.
2. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
3. Staar Survey.
4. "Is LASIK Safe? What You Need to Know." Refractive Surgery Council, 13 Oct. 2022, https://americanrefractivesurgerycouncil.org/is-lasik-safe/.
5. Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmol. 2017;135(1):13-22. doi:10.1001/jamaophthalmol.2016.4587. Available: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2587831. Accessed March 1, 2021. 6. Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Ophthalmol. 2009 Jul;148(1):164-70.

The EVO ICL™is an Implantable Collamer Lens that works in conjunction with the natural lens to correct vision problems such as nearsightedness (myopia) and astigmatism. Unlike traditional contact lenses that are placed on the surface of the eye, the EVO ICL™ is surgically placed just below the surface of the eye, between the iris and the natural lens.

One of the key benefits of the EVO ICL™ is that it is made up of a biocompatible material. The proprietary material is composed of collagen and other naturally occurring compounds found in the body. This allows the lens to be easily accepted by the eye without causing an immune response or rejection.

Another advantage of the EVO ICL™ is its size. At just a few millimeters, the EVO ICL™ lens, is about the size of a button in diameter. The lens is much smaller than a typical soft contact lens. This small size allows for a minimally invasive surgical procedure, with a fast recovery time for patients.

Additionally, the EVO ICL™ offers several other benefits over traditional vision correction methods such as LASIK. Because no tissue is removed from the front surface of the eye during the procedure, patients may experience less dryness and discomfort following surgery. The lens also offers excellent night vision and built-in UV protection.

The EVO ICL™ has been used in over 2 million procedures worldwide, making it a safe and effective option for many patients seeking vision correction surgery. And like all surgical procedures, side effects1 are possible. If you are interested in learning more about the EVO ICL™ and whether it is right for you, contact Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego for a consultation.

The EVO ICL™ offers a number of benefits to consider when deciding which vision correction procedure is right for you including:

  1. Sharp, clear vision 1
  2. Excellent night vision 2
  3. Does not usually cause dry eye syndrome 3
  4. Short surgery recovery times
  5. Does not remove corneal tissue
  6. Removable by your doctor
  7. Built in protection from UV rays.

 

Because the lens is implanted within the eye, it usually does not suffer from the same potential for displacement, movement, or discomfort as contact lenses on the surface of the eye. This means that patients can enjoy stable, long-term vision correction without the need for frequent adjustments or replacements.

The EVO ICL offers sharp clear vision3 during the day and also at night4-6.

Another advantage of the EVO ICL™ is its biocompatibility. The collamer material used in the lens is well-tolerated by the body, reducing the risk of inflammation, infection, or other complications following surgery. The EVO ICL™ also preserves the cornea, which can be particularly beneficial for patients with thin corneas or those who may not be good candidates for LASIK.

The lens also includes a built-in UV filter, helping to protect the eyes from damage caused by the sun's rays. Patients who choose the EVO ICL™ can enjoy improved vision, greater comfort, and low risk of complications.

At Clearview Eye and Laser Medical Center in San Diego, California, Dr. Sandy T. Feldman is dedicated to helping patients achieve optimal vision. Contact us today to learn more about the benefits of the EVO ICL™ and schedule a free evaluation to determine whether this may be the right option for you.

1.Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009
2. Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125
3. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.
4. Schallhorn S, Tanzer D, Sanders DR, Sanders M, Brown M, Kaupp SE. Night driving simulation in a randomized prospective comparison of Visian toric implantable collamer lens and conventional PRK for moderate to high myopic astigmatism. J Refract Surg. 2010 May;26(5):321-6.
5. Takashi KojimaYoshihiro KitazawaTomoaki NakamuraMasahide TakahashiKazutaka KamiyaKazuo IchikawaAkihito Igarashi , Kimiya Shimizu. Prospective Randomized Multicenter Comparison of the Clinical Outcomes of V4c and V5 Implantable Collamer Lenses: A Contralateral Eye Study. J Ophthalmology. 2018 Sep 5;2018:7623829.
6. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15.

The EVO ICL™ [implantable collamer lens] may be a good solution for people with nearsightedness and astigmatism wanting a flexible and biocompatible vision correction option that does not remove tissue from the eye. It is also a good solution for many patients with high nearsighted prescriptions or thin corneas who are not candidates for laser vision correction.

Ideal candidates for the EVO ICL™:

  1. Are between the ages of 21 and 45
  2. Are seeking a vision correction solution for moderate to severe nearsightedness (with or without astigmatism)
  3. Have a stable prescription that has not changed within the last year
  4. Have good ocular health with no history of glaucoma, iritis, or diabetic eye disease

Patients seeking vision correction who meet the above criteria can consider EVO ICL™ surgery in San Diego. Additionally, patients where dry eye is a concern, may still be candidates for the procedure, as the EVO ICL™ does not generally exacerbate dry eye syndrome. Even patients who have thin corneas or high nearsighted prescriptions, and those who have previously been told they are not a candidate for LASIK or PRK may also benefit from the EVO ICL™.

It is important for patients to undergo a thorough eye examination and consultation with an experienced eye surgeon to determine if they are a good candidate for EVO ICL™ surgery. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center will evaluate your medical history, visual acuity, ocular health, pupil size1, and the thickness of their cornea as part of your consultation to ensure the safety and effectiveness of the procedure for your eyes.

At Clearview Eye and Laser Medical Center in San Diego, Dr. Sandy T. Feldman is a recognized leader in refractive surgery and is the #1 EVO ICL™ surgeon in San Diego. She has performed numerous EVO ICL™ procedures with excellent outcomes. Patients who are considering EVO ICL™ surgery can trust Dr. Feldman and her experienced team to provide personalized care and the latest advanced technology for the best possible results for you and your eyes.

1. Lim DH, Lyu IJ, Choi SH, Chung ES, Chung TY. Risk factors associated with night vision disturbances after phakic intraocular lens implantation.�Am J Ophthalmol. 2014 Jan;157(1):135-141.

The EVO ICL™ implantation procedure involves several steps to ensure the safety and effectiveness of the treatment for you. Before the procedure, Dr. Sandy T. Feldman and her team will perform a comprehensive eye examination to determine your eligibility for the EVO ICL™ lens implantation. After your initial examination at Clearview to determine that the EVO ICL™ is right for you, you will schedule your procedure. An additional visit is usually necessary prior to the procedure for additional measurements, and a discussion about the benefits as well as risks of the procedure.

The EVO ICL™ procedure typically takes 20 to 30 minutes in an outpatient center. On the day of the procedure, your eyes will be dilated and then in surgery, numbed with a comfort drop (an anesthetic eye drop). Dr. Sandy T. Feldman will implant the EVO ICL™ in the space between the iris (colored part of the eye) and the natural lens and align the lens according to the specifications recommended for your eyes. The lens will remain in place permanently and will not be visible to others. Usually, you cannot feel the lens.

Following the procedure, you may experience some minor discomfort, such as eye irritation or dryness, which can be managed with eye drops or medication. At Clearview Eye and Laser Medical Center, we will re-evaluate your eyes two to four hours after the procedure. Follow up appointments are scheduled to ensure proper healing and to monitor your vision improvement.

Overall, the EVO ICL™ procedure is a safe and effective vision correction option for patients with moderate to severe nearsightedness and astigmatism.1,2 The procedure is quick and can provide long-lasting results, making it an attractive alternative to traditional laser vision correction.

1. Summary of Safety and Efficacy Data, FDA 2022.
2. FDA Patient Education Booklet.�

Yes; although the EVO ICL™ is intended to provide permanent vision correction, it can be removed or upgraded by your surgeon if ever needed.

While the EVO ICL™ is designed to provide long-term vision correction, there are situations in which removal or upgrading may be necessary. For example, if a patient develops cataracts later in life, the EVO ICL™ will be removed at the same time as the cataract procedure.

The process of removing the EVO ICL™ is typically straightforward and can usually be performed in an outpatient setting. Dr. Sandy T Feldman will first numb the eye with local anesthesia to minimize any discomfort during the procedure. The lens is then carefully extracted using specialized instruments and techniques.

After the EVO ICL™ has been removed, patients may experience some temporary vision changes and mild discomfort as their eyes adjust. However, most patients resume normal activities shortly following the procedure.

It is important to note that while the EVO ICL™ can be removed or upgraded if necessary, the vast majority of patients are highly satisfied with their results and do not experience any complications or issues requiring removal. It is always important to determine the best course of action for your individual situation.

No, you should not feel the EVO ICL™ lens once it has been implanted inside your eye. The EVO ICL™ is designed to be a biocompatible and flexible implant that is placed inside the eye to correct nearsightedness and astigmatism. Because of its unique properties, the EVO ICL™ is not typically felt by the patient once it has been implanted.

During the procedure, the EVO ICL™ is carefully placed in the space between the iris and the natural lens of the eye, where it stays in place without any need for sutures or other fixation techniques. Once the lens has been implanted, patients typically experience improved vision without any discomfort or awareness of the lens inside the eye.

As with any surgery, some patients may experience temporary discomfort or sensitivity following the procedure due to the openings that are made. These symptoms are typically mild and can be managed with over-the-counter pain relievers and lubricating eye drops, and usually resolve within a few days.

If you have or have questions about the EVO ICL™ procedure, what to expect during and after the surgery, be sure to discuss these with Dr. Sandy T. Feldman during your consultation. She and her team can help you determine whether the EVO ICL™ is the right choice for your vision correction needs. We are happy to speak with you so feel welcome to call with any questions you may have.

No, you should not feel the EVO ICL™ lens once it has been implanted inside your eye. The EVO ICL™ is designed to be a biocompatible and flexible implant that is placed inside the eye to correct nearsightedness and astigmatism. Because of its unique properties, the EVO ICL™ is not typically felt by the patient once it has been implanted.

During the procedure, the EVO ICL™ is carefully placed in the space between the iris and the natural lens of the eye, where it stays in place without any need for sutures or other fixation techniques. Once the lens has been implanted, patients typically experience improved vision without any discomfort or awareness of the lens inside the eye.

As with any surgery, some patients may experience temporary discomfort or sensitivity following the procedure due to the openings that are made. These symptoms are typically mild and can be managed with over-the-counter pain relievers and lubricating eye drops, and usually resolve within a few days.

If you have or have questions about the EVO ICL™ procedure, what to expect during and after the surgery, be sure to discuss these with Dr. Sandy T. Feldman during your consultation. She and her team can help you determine whether the EVO ICL™ is the right choice for your vision correction needs. We are happy to speak with you so feel welcome to call with any questions you may have.

Yes. Every medical procedure has some risks associated with it. 1-3 Potential complications of the EVO ICL™ procedure, although rare, include inflammation, an increase in eye pressure, infection or the need for an additional procedure, like an EVO ICL exchange. While these potential risks are mitigated as much as possible, they can typically be addressed. Early detection and treatment may allow for few if any long-term side effects but serious side effects can occur.

1. Summary of Safety and Efficacy Data, FDA 2022.>
2. FDA Patient Education Booklet.
3. Zhang H, Gong R, Zhang X, Deng Y. Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation. �Int Ophthalmol. 2022 Nov;42(11):3625-3641.
4. Lim DH, Lyu IJ, Choi SH, Chung ES, Chung TY. Risk factors associated with night vision disturbances after phakic intraocular lens implantation. Am J Ophthalmol. 2014 Jan;157(1):135-141.

Yes, The EVO ICL™ lens has been approved by the US Food and Drug Administration (FDA) for use in the United States1,2. The FDA approval process involves rigorous testing and evaluation to ensure the safety and efficacy of medical devices. The EVO ICL™ lens underwent clinical trials to evaluate its safety and effectiveness, and the results of these trials were submitted to the FDA and approved for use in the United States in March 2022.

In addition to FDA approval, the EVO ICL™ lens has also received approval from regulatory agencies in other countries, including Europe and Japan. This global approval further demonstrates the safety and effectiveness of the EVO ICL™ lens for vision correction.

At Clearview Eye and Laser Medical Center in San Diego, we are proud to be the #1 EVO ICL™ provider in San Diego. We offer it as a safe and effective vision correction option for our patients. Our experienced team, led by Dr. Sandy T. Feldman, has extensive experience with the EVO ICL™ lens and can help determine if it is the right option for you.

1. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035
2. https://investors.staar.com/press-releases/press-release-details/2022/STAAR-Surgical-Announces-U.S.-FDA-Approval-of-EVO-Visian-Implantable-Collamer-Lenses/default.aspx

The EVO ICL™ has been used in Europe and Asia for over a decade and more than 2,000,000 procedures have been successfully performed. The EVO ICL™ was available worldwide for about 10 years prior to FDA approval. It is likely the most tested lens of its kind prior to its FDA approval.

At Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman has extensive experience in performing the EVO ICL™ procedure, and she and her team can help determine if this treatment is right for your individual eyes. As with any medical procedure, it is important to discuss the potential risks and benefits with and to carefully follow post-operative instructions to ensure the best possible outcome.

Yes, the EVO ICL™ surgery can treat nearsighted prescriptions, known as myopia, from a low 3 diopters to a high of 20 diopters with or without astigmatism. The amount of astigmatism that can be treated ranges from 1.0 to 4.0 diopters. Above the level of nearsightedness of 15 diopters, the lens will reduce but not fully correct nearsightedness so glasses, contact lenses or laser vision correction may be required. The prescription that is still left can then be treated with laser vision correction if safe for your eyes and you desire to be free of glasses and/or contact lenses.

To determine if you are a suitable candidate for the EVO ICL™ procedure, Dr Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center will assess your prescription, eye health, and other factors to determine the most appropriate treatment option for your vision and unique lifestyle needs.

Dr. Sandy T. Feldman is among the most experienced EVO ICL™ surgeons in the US and is the #1 EVO ICL™ surgeon in San Diego, CA. At Clearview, we offer personalized care and use the latest technology to deliver the best possible outcome for each of our patients.

The EVO ICL™, or implantable collamer lens, is designed to be a permanent vision correction solution and last an individual's lifetime. According to clinical studies, the EVO ICL™ has a high rate of long-term success, with many patients reporting stable vision for up to 20 years or more after the procedure.1 In fact, a study published in the Review of Ophthalmology reported that 98.9% of patients who received the EVO ICL™ had 20/32 or better vision at 10 years post-surgery.2

The EVO ICL™�is made up of a biocompatible material called which is a collamer of collagen that is designed to be long-lasting and resistant to degradation and work well in conjunction with your natural eye. The lens is also designed to be reversible, meaning that it can be removed or replaced if necessary. However, this is a rare occurrence and is usually only done in cases of complications or if a patient's vision needs change significantly over time.

The longevity of the EVO ICL™ depends on several factors, including the patient's age, lifestyle, and overall eye health. Regular eye exams and follow-up visits are recommended to ensure that the lens is functioning properly and to monitor any changes in vision or health of the eye over time.

References:
  1. https://theophthalmologist.com/business-profession/evo-icl-long-lasting-quality-of-vision
  2. https://www.reviewofophthalmology.com/article/a-first-look-at-the-evo-icl Review of Ophthalmology, A first Look at the EVO ICL, June 10, 2022.

The EVO ICL™ procedure is considered worth it for many people who are looking for a permanent solution to their vision problems. The EVO ICL™ procedure is a great alternative to LASIK surgery. Like LASIK, it can even save you money in the long run. When comparing the cost of glasses, contact lenses, contact lens solutions, cases etc., people often see a monetary savings through vision correction surgery. Although more difficult to quantify, you also will also save time as you usually are not dependent on glasses and/or contact lenses.

There is also another immeasurable benefit to you: having the freedom of being able to wake up and see the world clearly without the hassle of glasses and contacts. This makes people more confident and is priceless.

Studies have shown that patients who undergo EVO ICL™ surgery report high levels of satisfaction with their results. STAAR Surgical. Over 2,000,000 EVO procedures have been performed around the world and 99.4% of patients would have the procedure again.3

Ultimately, whether the EVO ICL™ procedure is worth it for an individual will depend on their specific vision needs and preferences. A consultation with an experienced ophthalmologist like Dr. Sandy T. Feldman can help determine if EVO ICL™ surgery is the right choice for you. At Clearview Eye and Laser Medical Center in San Diego, we have helped many patients achieve clear, crisp vision with EVO ICL™ surgery.

The truly immeasurable benefit to you is: having the freedom of being able to wake up and see the world clearly without the hassle of glasses and contacts. This makes people more confident and is priceless.

References:
  1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology. 2018: 12: 2427-2438.

Sandy T. Feldman, MD has been performing the Visian implantable collamer lens (ICL) procedure since FDA approval in the U.S. in 2005 and the EVO ICL™ since FDA approval in 2022. She has helped many patients achieve better vision and is the #1 Visian ICL and EVO ICL™ surgeon in San Diego1 and a leading surgeon in the US for this technology as well. As you may have read already on the Clearview Eye and Laser Medical Center website, she is quite experienced and has lectured nationally and internationally on modern vision surgical correction techniques.

Sandy T. Feldman, MD has been performing the implantable collamer lens procedure since FDA approval in the U.S. in 2005 and has helped many patients achieve better vision. She has been the number one Visian ICL and EVO ICL™ surgeon in San Diego2 and a leading surgeon in the US for this technology as well.

Dr. Feldman is a renowned ophthalmologist who has dedicated her career to helping patients improve their vision. She has been practicing for over 25 years and has performed thousands of successful vision correction surgeries. Dr. Feldman has been a pioneer in the field of implantable collamer lenses, including the EVO ICL™, since its inception. She has been performing this procedure for nearly two decades and has extensive experience in selecting the best vision correction procedure for each individual patient. Dr. Feldman is considered one of the top EVO ICL™ surgeons in the country and has been recognized for her expertise by numerous organizations.

In addition to her surgical expertise, Dr. Feldman is also a respected researcher and author in the field of ophthalmology. She has published numerous articles in peer-reviewed journals and has contributed to several textbooks on vision correction surgery. Dr. Feldman is committed to staying at the forefront of her field and regularly attends conferences and training sessions to stay up-to-date on the latest advancements in ophthalmology.

If you are considering EVO ICL™ surgery, Dr. Feldman and the team at Clearview Eye and Laser Medical Center can provide you with the expert care and guidance you need to make an informed decision about your vision.

References:
  1. https://theophthalmologist.com/business-profession/evo-icl-long-lasting-quality-of-vision
  2. Per Staar Surgical, the manufacturer of the EVO ICL™

The EVO Implantable Collamer Lens surgery has a very high success rate, with 98.9% of patients achieving uncorrected vision of 20/32 vision or better, and 80% of patients achieving 20/20 uncorrected vision or better.1,2 Patients are so satisfied, that 99.4% of patients say they would have the procedure again.8

The Visian ICL has had success rates as high as 96% of eyes achieving 20/20 or better and 100% of patients achieved 20/20 or better uncorrected vision, three months after surgery in military warfighters.

Dr Sandy T. Feldman is the leading provider of the EVO ICL™ procedure in San Diego and has seen the excellent results resulting in much happiness for our patients at Clearview. Although it is important to understand the general overall success rate of the EVO ICL™, the most important question is if the EVO ICL™ will be successful for your unique vision. To determine if you are a candidate, please schedule a complimentary evaluation with Dr. Sandy T. Feldman and the Team at Clearview Eye and Laser Medical Center today!

Not everyone is a candidate for the EVO ICL™ implantable collamer lens procedure. If your prescription for glasses changes significantly each year, if you have mild nearsightedness [below 3 diopters), moderate to severe damage to the optic nerve from glaucoma or are pregnant, you may not be a good candidate for the EVO ICL™ surgery at this point in time.

In addition to those mentioned above, patients with certain medical conditions such as certain autoimmune diseases or uncontrolled diabetes, as well as those with a history of eye disease such as uveitis or keratitis, may also not be suitable candidates for EVO ICL™ surgery. Patients diagnosed with cataracts should note that every patient's situation is unique, and a thorough consultation with an experienced ophthalmologist such as Dr. Sandy T. Feldman is necessary to determine if EVO ICL™ surgery is a good option for you. It may not be if you already have some clouding of your natural lens. Other implantable lenses may be a better option for you. During the consultation, Dr. Feldman and her team will evaluate your eyes and overall health to determine if you are a suitable candidate for the procedure. It is important to be honest about any medical conditions you have and any medications you are taking during the consultation, as these factors may impact your eligibility for the procedure.

When you undergo a consultation at Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman and her team will give you a personalized recommendation on which procedure is best for you based on your eyes, lifestyle and health. If EVO ICL™ surgery is not an option for you, Dr. Feldman and her team will work with you to find an alternative solution to meet your vision correction needs.

A comprehensive eye examination should be performed to ensure that you are a good candidate for the EVO ICL™ implantable collamer lens. This will include a measurement of your prescription with and without dilation of your eyes. Corneal topography to map the surface of the cornea, intraocular pressure measurement and testing to ensure there is enough space inside your eye where the lens will be positioned. Additionally, a dilated eye exam should be performed as extremely nearsighted people have a higher chance of retinal tears. The size of the eye will help determine the optimal size of ICL to ensure proper fit inside the eye. This information is critical in ensuring that you are a good candidate for the EVO ICL™ surgery. Dr Sandy T. Feldman and the team at Clearview are familiar with EVO ICLs and the necessary testing needed to ensure optimal results.

Most people can return to their normal activities, i.e. work and driving within a day or two after surgery. However, ask Dr. Sandy T. Feldman and her team about the best time to return to work for your type of work. Please follow the instructions you are given. It may take some time to let your eyes heal properly. Although most people can return to their normal activities within a day or two after EVO ICL™ surgery, it is important to follow post-operative instructions provided by Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center. It is recommended to avoid strenuous activities such as heavy lifting or exercise for a week after surgery to prevent complications. Patients should also avoid rubbing their eyes and wear protective eyewear during the recovery period to minimize the risk of infection.

It is common for patients to experience some mild discomfort, blurry vision, and sensitivity to light for a few days after the surgery. Dr. Feldman may recommend using eye drops to alleviate discomfort and aid in the healing process. Patients should also avoid swimming or soaking in hot tubs for two weeks after surgery to prevent infection.

Follow-up appointments with Dr. Feldman will be scheduled to ensure that the healing process is progressing as expected. The number of follow-up visits will depend on individual patient needs. Overall, by following the post-operative instructions and attending follow-up appointments, patients can ensure a successful and speedy recovery after EVO ICL™ surgery.

Vision is usually improved immediately upon sitting up or shortly following surgery and will likely improve from that point.

You should avoid rubbing your eyes, wearing eye makeup, swimming and heavy lifting for at least two weeks after surgery. You should just take it easy and let your eyes recover. You will also need to use medicated eye drops and non-preserved artificial tears.

After undergoing EVO ICL™ implantable collamer lens procedure, there are several precautions that you should take to ensure the best possible outcome. You should avoid rubbing or touching your eyes for at least two weeks after surgery. Rubbing your eyes can lead to irritation or infection, which can slow down the healing process. You should also avoid wearing eye makeup during the first week after the surgery to avoid infection.

Swimming should be avoided for at least two weeks after surgery as the water in the pool or ocean can contain bacteria or other contaminants that can cause infection or irritation. You should also avoid heavy lifting, bending over, or straining for at least a week after surgery to reduce the risk of increased eye pressure, which can affect your vision. You should just take it easy and let your eyes recover.

In addition, Dr. Feldman may prescribe medicated eye drops and non-preserved artificial tears to reduce inflammation, promote healing and prevent dryness. It is important to follow the instructions provided by Dr. Sandy T. Feldman and her team and to attend all follow-up appointments to ensure the best possible results.

The vast majority of patients who have undergone the EVO ICL™ implantable collamer lens no longer rely on corrective lenses for their everyday activities. During the consultation prior to the EVO ICL™, Dr. Sandy T. Feldman and her associates will discuss with you whether this is likely to occur. If you have a prescription above 15 diopters of nearsightedness or greater than 4 diopters of astigmatism, glasses may be needed for certain activities, like driving at night.

According to a study published in the Journal of Cataract and Refractive Surgery, over 95% of patients who received the EVO ICL™ implant reported that they no longer needed glasses or contact lenses for their daily activities.1

It's important to note that there are some cases where glasses may still be needed after the EVO ICL™ surgery. For example, patients with an extremely high degree of nearsightedness or astigmatism may still need glasses for certain activities, such as driving at night. Additionally, some patients may experience minor residual refractive errors, which can be corrected with glasses or additional surgery if needed. The EVO ICL works in harmony with your natural vision. As such, it does not correct for presbyopia so patients who have vision correction with the EVO ICL may need reading glasses for near vision in their mid 40s and later.

During the consultation process at Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman and her team will discuss the expected outcomes and potential need for glasses following the EVO ICL™ procedure. It's important to follow all post-operative instructions to ensure the best possible results and minimize the need for corrective lenses.

References:
  1. Sanders D, Sanders A, Dejaco-Ruhswurm I, et al. Five-year analysis of the safety and efficacy of the implantable collamer lens for the correction of myopia. J Cataract Refract Surg. 2018;44(11):1362-1370. doi:10.1016/j.jcrs.2018.08.036

The EVO ICL™ is an Implantable Collamer Lens that works in conjunction with your natural lens to correct vision problems such as nearsightedness (myopia) and astigmatism. Unlike traditional contact lenses that sit on the surface of your eye, the EVO ICL™ is surgically implanted just beneath the surface, between the iris and the natural lens.

One of the key benefits of the EVO ICL™ is that it's made from a biocompatible material. This proprietary material, composed of collagen and other naturally occurring compounds in the body, ensures the lens is readily accepted by the eye without triggering an immune response or rejection.

Another advantage of the EVO ICL™ is its size. At just a few millimeters in diameter—about the size of a button—the lens allows for a minimally invasive surgical procedure and a quick recovery time for patients.

Additionally, the EVO ICL™ offers several benefits over traditional vision correction methods such as LASIK. Since no tissue is removed from the cornea during the procedure, patients often experience less dryness and discomfort following surgery. The lens also provides excellent night vision and built-in UV protection.

The EVO ICL™ has been utilized in over 2 million procedures worldwide, establishing it as a safe and effective option for many individuals seeking vision correction surgery. Like all surgical procedures, potential side effects exist. If you are interested in learning more about the EVO ICL™ and determining if it is right for you, please contact Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego for a consultation.

The EVO ICL™ offers a number of benefits to consider when deciding which vision correction procedure is right for you, including:

  • Sharp, clear vision1
  • Excellent night vision2
  • Does not usually cause dry eye syndrome3
  • Short surgery recovery times
  • Does not remove corneal tissue
  • Removable by your doctor
  • Built-in protection from UV rays

Because the lens is implanted within the eye, it usually does not suffer from the same potential for displacement, movement, or discomfort as contact lenses on the surface of the eye. This means that patients can enjoy stable, long-term vision correction without the need for frequent adjustments or replacements.

The EVO ICL offers sharp, clear vision3 during the day and also at night4-6.

Another advantage of the EVO ICL™ is its biocompatibility. The collamer material used in the lens is well-tolerated by the body, reducing the risk of inflammation, infection, or other complications following surgery. The EVO ICL™ also preserves the cornea, which can be particularly beneficial for patients with thin corneas or those who may not be good candidates for LASIK.

The lens also includes a built-in UV filter, helping to protect the eyes from damage caused by the sun's rays. Patients who choose the EVO ICL™ can enjoy improved vision, greater comfort, and a low risk of complications.

At Clearview Eye and Laser Medical Center in San Diego, California, Dr. Sandy T. Feldman is dedicated to helping patients achieve optimal vision. Contact us today to learn more about the benefits of the EVO ICL™ and schedule a free evaluation to determine whether this may be the right option for you.

  1. Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009
  2. Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117–125
  3. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.
  4. Schallhorn S, Tanzer D, Sanders DR, Sanders M, Brown M, Kaupp SE. Night driving simulation in a randomized prospective comparison of Visian toric implantable collamer lens and conventional PRK for moderate to high myopic astigmatism. J Refract Surg. 2010 May;26(5):321-6.
  5. Takashi Kojima, Yoshihiro Kitazawa, Tomoaki Nakamura, Masahide Takahashi, Kazutaka Kamiya, Kazuo Ichikawa, Akihito Igarashi , Kimiya Shimizu. Prospective Randomized Multicenter Comparison of the Clinical Outcomes of V4c and V5 Implantable Collamer Lenses: A Contralateral Eye Study. J Ophthalmology. 2018 Sep 5;2018:7623829.
  6. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15.

The EVO ICL™ [implantable collamer lens] may be a good solution for people with nearsightedness and astigmatism wanting a flexible and biocompatible vision correction option that does not remove tissue from the eye. It is also a good solution for many patients with high nearsighted prescriptions or thin corneas who are not candidates for laser vision correction.

Ideal candidates for the EVO ICL™:

  • Are between the ages of 21 and 45
  • Are seeking a vision correction solution for moderate to severe nearsightedness (with or without astigmatism)
  • Have a stable prescription that has not changed within the last year
  • Have good ocular health with no history of glaucoma, iritis, or diabetic eye disease

Patients seeking vision correction who meet the above criteria can consider EVO ICL™ surgery in San Diego. Additionally, patients where dry eye is a concern, may still be candidates for the procedure, as the EVO ICL™ does not generally exacerbate dry eye syndrome. Even patients who have thin corneas or high nearsighted prescriptions, and those who have previously been told they are not a candidate for LASIK or PRK may also benefit from the EVO ICL™.

It is important for patients to undergo a thorough eye examination and consultation with an experienced eye surgeon to determine if they are a good candidate for EVO ICL™ surgery. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center will evaluate your medical history, visual acuity, ocular health, pupil size1, and the thickness of their cornea as part of your consultation to ensure the safety and effectiveness of the procedure for your eyes.

At Clearview Eye and Laser Medical Center in San Diego, Dr. Sandy T. Feldman is a recognized leader in refractive surgery and is the #1 EVO ICL™ surgeon in San Diego. She has performed numerous EVO ICL™ procedures with excellent outcomes. Patients who are considering EVO ICL™ surgery can trust Dr. Feldman and her experienced team to provide personalized care and the latest advanced technology for the best possible results for you and your eyes.

1. Lim DH, Lyu IJ, Choi SH, Chung ES, Chung TY. Risk factors associated with night vision disturbances after phakic intraocular lens implantation. Am J Ophthalmol. 2014 Jan;157(1):135-141.

The EVO ICL™ implantation procedure involves several steps to ensure the safety and effectiveness of the treatment for you. Before the procedure, Dr. Sandy T. Feldman and her team will perform a comprehensive eye examination to determine your eligibility for the EVO ICL™ lens implantation. After your initial examination at Clearview to determine that the EVO ICL™ is right for you, you will schedule your procedure. An additional visit is usually necessary prior to the procedure for additional measurements, and a discussion about the benefits as well as risks of the procedure.

The EVO ICL™ procedure typically takes 20 to 30 minutes in an outpatient center. On the day of the procedure, your eyes will be dilated and then in surgery, numbed with a comfort drop (an anesthetic eye drop). Dr. Sandy T. Feldman will implant the EVO ICL™ in the space between the iris (colored part of the eye) and the natural lens and align the lens according to the specifications recommended for your eyes. The lens will remain in place permanently and will not be visible to others. Usually, you cannot feel the lens.

Following the procedure, you may experience some minor discomfort, such as eye irritation or dryness, which can be managed with eye drops or medication. At Clearview Eye and Laser Medical Center, we will re-evaluate your eyes two to four hours after the procedure. Follow up appointments are scheduled to ensure proper healing and to monitor your vision improvement.

Overall, the EVO ICL™ procedure is a safe and effective vision correction option for patients with moderate to severe nearsightedness and astigmatism.1,2 The procedure is quick and can provide long-lasting results, making it an attractive alternative to traditional laser vision correction.

Yes; although the EVO ICL™ is intended to provide permanent vision correction, it can be removed or upgraded by your surgeon if ever needed.

While the EVO ICL™ is designed to provide long-term vision correction, there are situations in which removal or upgrading may be necessary. For example, if a patient develops cataracts later in life, the EVO ICL™ will be removed at the same time as the cataract procedure.

The process of removing the EVO ICL™ is typically straightforward and can usually be performed in an outpatient setting. Dr. Sandy T Feldman will first numb the eye with local anesthesia to minimize any discomfort during the procedure. The lens is then carefully extracted using specialized instruments and techniques.

After the EVO ICL™ has been removed, patients may experience some temporary vision changes and mild discomfort as their eyes adjust. However, most patients resume normal activities shortly following the procedure.

It is important to note that while the EVO ICL™ can be removed or upgraded if necessary, the vast majority of patients are highly satisfied with their results and do not experience any complications or issues requiring removal. It is always important to determine the best course of action for your individual situation.

No, you should not feel the EVO ICL™ lens once it has been implanted inside your eye. The EVO ICL™ is designed to be a biocompatible and flexible implant that is placed inside the eye to correct nearsightedness and astigmatism. Because of its unique properties, the EVO ICL™ is not typically felt by the patient once it has been implanted.

During the procedure, the EVO ICL™ is carefully placed in the space between the iris and the natural lens of the eye, where it stays in place without any need for sutures or other fixation techniques. Once the lens has been implanted, patients typically experience improved vision without any discomfort or awareness of the lens inside the eye.

As with any surgery, some patients may experience temporary discomfort or sensitivity following the procedure due to the openings that are made. These symptoms are typically mild and can be managed with over-the-counter pain relievers and lubricating eye drops, and usually resolve within a few days.

If you have or have questions about the EVO ICL™ procedure, what to expect during and after the surgery, be sure to discuss these with Dr. Sandy T. Feldman during your consultation. She and her team can help you determine whether the EVO ICL™ is the right choice for your vision correction needs. We are happy to speak with you so feel welcome to call with any questions you may have.

No, the EVO ICL™ lens is discreetly placed behind the iris, where only an eye doctor can detect it using a biomicroscope. Designed to be invisible to others, the EVO ICL™ is positioned to work in conjunction with your natural lens to enhance your vision. Unlike glasses or contact lenses that sit on the surface of the eye and are visible, the EVO ICL™ remains hidden behind the colored part of your eye, making it unseen by others.

The EVO ICL™ is crafted from a biocompatible material known as Collamer, a combination of collagen, which has been safely used in implantable lenses for over 20 years. This soft, flexible material is well-tolerated by the eye and has proven to deliver excellent vision correction results.

Yes. Every medical procedure has some risks associated with it. 1 Potential complications of the EVO ICL™ procedure, although rare, include inflammation, an increase in eye pressure, infection or the need for an additional procedure, like an EVO ICL exchange. While these potential risks are mitigated as much as possible, they can typically be addressed. Early detection and treatment may allow for few if any long-term side effects but serious side effects can occur.

1. Zhang H, Gong R, Zhang X, Deng Y. Analysis of perioperative problems related to intraocular Implantable Collamer Lens (ICL) implantation. Int Ophthalmol. 2022 Nov;42(11):3625-3641.

Yes, The EVO ICL™ lens has been approved by the US Food and Drug Administration (FDA) for use in the United States1,2. The FDA approval process involves rigorous testing and evaluation to ensure the safety and efficacy of medical devices. The EVO ICL™ lens underwent clinical trials to evaluate its safety and effectiveness, and the results of these trials were submitted to the FDA and approved for use in the United States in March 2022.

In addition to FDA approval, the EVO ICL™ lens has also received approval from regulatory agencies in other countries, including Europe and Japan. This global approval further demonstrates the safety and effectiveness of the EVO ICL™ lens for vision correction.

At Clearview Eye and Laser Medical Center in San Diego, we are proud to be the #1 EVO ICL™ provider in San Diego. We offer it as a safe and effective vision correction option for our patients. Our experienced team, led by Dr. Sandy T. Feldman, has extensive experience with the EVO ICL™ lens and can help determine if it is the right option for you.

  1. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035
  2. https://investors.staar.com/press-releases/press-release-details/2022/STAAR-Surgical-Announces-U.S.-FDA-Approval-of-EVO-Visian-Implantable-Collamer-Lenses/default.aspx

The EVO ICL™ has been used in Europe and Asia for over a decade and more than 2,000,000 procedures have been successfully performed. The EVO ICL™ was available worldwide for about 10 years prior to FDA approval. It is likely the most tested lens of its kind prior to its FDA approval.

At Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman has extensive experience in performing the EVO ICL™ procedure, and she and her team can help determine if this treatment is right for your individual eyes. As with any medical procedure, it is important to discuss the potential risks and benefits with and to carefully follow post-operative instructions to ensure the best possible outcome.

Yes, the EVO ICL™ surgery can treat nearsighted prescriptions, known as myopia, from a low 3 diopters to a high of 20 diopters with or without astigmatism. The amount of astigmatism that can be treated ranges from 1.0 to 4.0 diopters. Above the level of nearsightedness of 15 diopters, the lens will reduce but not fully correct nearsightedness so glasses, contact lenses or laser vision correction may be required. The prescription that is still left can then be treated with laser vision correction if safe for your eyes and you desire to be free of glasses and/or contact lenses.

To determine if you are a suitable candidate for the EVO ICL™ procedure, Dr Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center will assess your prescription, eye health, and other factors to determine the most appropriate treatment option for your vision and unique lifestyle needs.

Dr. Sandy T. Feldman is among the most experienced EVO ICL™ surgeons in the US and is the #1 EVO ICL™ surgeon in San Diego, CA. At Clearview, we offer personalized care and use the latest technology to deliver the best possible outcome for each of our patients.

The EVO ICL™ , or implantable collamer lens, is designed to be a permanent vision correction solution and last an individual’s lifetime. According to clinical studies, the EVO ICL™ has a high rate of long-term success, with many patients reporting stable vision for up to 20 years or more after the procedure.1 In fact, a study published in the Review of Ophthalmology reported that 98.9% of patients who received the EVO ICL™ had 20/32 or better vision at 10 years post-surgery.2

The EVO ICL™ is made up of a biocompatible material which is called a collamer of collagen that is designed to be long-lasting and resistant to degradation and work well in conjunction with your natural eye. The lens is also designed to be reversible, meaning that it can be removed or replaced if necessary. However, this is a rare occurrence and is usually only done in cases of complications or if a patient's vision needs to change significantly over time.

The longevity of the EVO ICL™ depends on several factors, including the patient's age, lifestyle, and overall eye health. Regular eye exams and follow-up visits are recommended to ensure that the lens is functioning properly and to monitor any changes in vision or health of the eye over time.

  1. https://theophthalmologist.com/business-profession/evo-icl-long-lasting-quality-of-vision
  2. https://www.reviewofophthalmology.com/article/a-first-look-at-the-evo-icl

The EVO ICL™ procedure is considered worth it for many people who are looking for a permanent solution to their vision problems. The EVO ICL™ procedure is a great alternative to LASIK surgery. Like LASIK, it can even save you money in the long run. When comparing the cost of glasses, contact lenses, contact lens solutions, cases etc., people often see monetary savings through vision correction surgery. Although more difficult to quantify, you also will also save time as you usually are not dependent on glasses and/or contact lenses.

There is also another immeasurable benefit to you: having the freedom of being able to wake up and see the world clearly without the hassle of glasses and contacts. This makes people more confident and is priceless.

Studies have shown that patients who undergo EVO ICL™ surgery report high levels of satisfaction with their results. STAAR Surgical. Over 2,000,000 EVO procedures have been performed around the world and 99.4% of patients would have the procedure again.1

Ultimately, whether the EVO ICL™ procedure is worth it for an individual will depend on their specific vision needs and preferences. A consultation with an experienced ophthalmologist like Dr. Sandy T. Feldman can help determine if EVO ICL™ surgery is the right choice for you. At Clearview Eye and Laser Medical Center in San Diego, we have helped many patients achieve clear, crisp vision with EVO ICL™ surgery.

The truly immeasurable benefit to you is: having the freedom of being able to wake up and see the world clearly without the hassle of glasses and contacts. This makes people more confident and is priceless.

  1. Packer M. The Implantable Collamer Lens with a central port: review of the literature.

Sandy T. Feldman, MD has been performing the Visian implantable collamer lens (ICL) procedure since FDA approval in the U.S. in 2005 and the EVO ICL™ since FDA approval in 2022. She has helped many patients achieve better vision and is the #1 Visian ICL and EVO ICL™ surgeon in San Diego1 and a leading surgeon in the US for this technology as well. As you may have read already on the Clearview Eye and Laser Medical Center website, she is quite experienced and has lectured nationally and internationally on modern vision surgical correction techniques.

Sandy T. Feldman, MD has been performing the implantable collamer lens procedure since FDA approval in the U.S. in 2005 and has helped many patients achieve better vision. She has been the number one Visian ICL and EVO ICL™ surgeon in San Diego1 and a leading surgeon in the US for this technology as well.

Dr. Feldman is a renowned ophthalmologist who has dedicated her career to helping patients improve their vision. She has been practicing for over 25 years and has performed thousands of successful vision correction surgeries. Dr. Feldman has been a pioneer in the field of implantable collamer lenses, including the EVO ICL™, since its inception. She has been performing this procedure for nearly two decades and has extensive experience in selecting the best vision correction procedure for each individual patient. Dr. Feldman is considered one of the top EVO ICL™ surgeons in the country and has been recognized for her expertise by numerous organizations.

In addition to her surgical expertise, Dr. Feldman is also a respected researcher and author in the field of ophthalmology. She has published numerous articles in peer-reviewed journals and has contributed to several textbooks on vision correction surgery. Dr. Feldman is committed to staying at the forefront of her field and regularly attends conferences and training sessions to stay up-to-date on the latest advancements in ophthalmology.

If you are considering EVO ICL™ surgery, Dr. Feldman and the team at Clearview Eye and Laser Medical Center can provide you with the expert care and guidance you need to make an informed decision about your vision.

  1. Per Staar Surgical, the manufacturer of the EVO ICL™

The EVO Implantable Collamer Lens surgery has a very high success rate, with 98.9% of patients achieving uncorrected vision of 20/32 vision or better, and 80% of patients achieving 20/20 uncorrected vision or better.1 Patients are so satisfied, that 99.4% of patients say they would have the procedure again.2

The Visian ICL has had success rates as high as 96% of eyes achieving 20/20 or better and 100% of patients achieved 20/20 or better uncorrected vision, three months after surgery in military warfighters.

Dr Sandy T. Feldman is the leading provider of the EVO ICL™ procedure in San Diego and has seen excellent results resulting in much happiness for our patients at Clearview. Although it is important to understand the general overall success rate of the EVO ICL™, the most important question is if the EVO ICL™ will be successful for your unique vision. To determine if you are a candidate, please schedule a complimentary evaluation with Dr. Sandy T. Feldman and the Team at Clearview Eye and Laser Medical Center today!

  1. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
  2. Patient Survey, STAAR Surgical ICL Data Registry, 2018

Not everyone is a candidate for the EVO ICL™ implantable collamer lens procedure. If your prescription for glasses changes significantly each year, if you have mild nearsightedness [below 3 diopters), moderate to severe damage to the optic nerve from glaucoma or are pregnant, you may not be a good candidate for the EVO ICL™ surgery at this point in time.

In addition to those mentioned above, patients with certain medical conditions such as certain autoimmune diseases or uncontrolled diabetes, as well as those with a history of eye disease such as uveitis or keratitis, may also not be suitable candidates for EVO ICL™ surgery. Patients diagnosed with cataracts should note that every patient's situation is unique, and a thorough consultation with an experienced ophthalmologist such as Dr. Sandy T. Feldman is necessary to determine if EVO ICL™ surgery is a good option for you. It may not be if you already have some clouding of your natural lens. Other implantable lenses may be a better option for you. During the consultation, Dr. Feldman and her team will evaluate your eyes and overall health to determine if you are a suitable candidate for the procedure. It is important to be honest about any medical conditions you have and any medications you are taking during the consultation, as these factors may impact your eligibility for the procedure.

When you undergo a consultation at Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman and her team will give you a personalized recommendation on which procedure is best for you based on your eyes, lifestyle and health. If EVO ICL™ surgery is not an option for you, Dr. Feldman and her team will work with you to find an alternative solution to meet your vision correction needs.

A comprehensive eye examination should be performed to ensure that you are a good candidate for the EVO ICL™ implantable collamer lens. This will include a measurement of your prescription with and without dilation of your eyes. Corneal topography to map the surface of the cornea, intraocular pressure measurement and testing to ensure there is enough space inside your eye where the lens will be positioned. Additionally, a dilated eye exam should be performed as extremely nearsighted people have a higher chance of retinal tears. The size of the eye will help determine the optimal size of ICL to ensure proper fit inside the eye. This information is critical in ensuring that you are a good candidate for the EVO ICL™ surgery. Dr Sandy T. Feldman and the team at Clearview are familiar with EVO ICLs and the necessary testing needed to ensure optimal results.

Most people can return to their normal activities, i.e. work and driving within a day or two after surgery. However, ask Dr. Sandy T. Feldman and her team about the best time to return to work for your type of work. Please follow the instructions you are given. It may take some time to let your eyes heal properly. Although most people can return to their normal activities within a day or two after EVO ICL™ surgery, it is important to follow post-operative instructions provided by Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center. It is recommended to avoid strenuous activities such as heavy lifting or exercise for a week after surgery to prevent complications. Patients should also avoid rubbing their eyes and wear protective eyewear during the recovery period to minimize the risk of infection.

It is common for patients to experience some mild discomfort, blurry vision, and sensitivity to light for a few days after the surgery. Dr. Feldman may recommend using eye drops to alleviate discomfort and aid in the healing process. Patients should also avoid swimming or soaking in hot tubs for two weeks after surgery to prevent infection. Follow-up appointments with Dr. Feldman will be scheduled to ensure that the healing process is progressing as expected. The number of follow-up visits will depend on individual patient needs. Overall, by following the post-operative instructions and attending follow-up appointments, patients can ensure a successful and speedy recovery after EVO ICL™ surgery.

Vision is usually improved immediately upon sitting up or shortly following surgery and will likely improve from that point.

You should avoid rubbing your eyes, wearing eye makeup, swimming and heavy lifting for at least two weeks after surgery. You should just take it easy and let your eyes recover. You will also need to use medicated eye drops and non-preserved artificial tears.

After undergoing EVO ICL™ implantable collamer lens procedure, there are several precautions that you should take to ensure the best possible outcome. You should avoid rubbing or touching your eyes for at least two weeks after surgery. Rubbing your eyes can lead to irritation or infection, which can slow down the healing process. You should also avoid wearing eye makeup during the first week after the surgery to avoid infection.

Swimming should be avoided for at least two weeks after surgery as the water in the pool or ocean can contain bacteria or other contaminants that can cause infection or irritation. You should also avoid heavy lifting, bending over, or straining for at least a week after surgery to reduce the risk of increased eye pressure, which can affect your vision. You should just take it easy and let your eyes recover.

In addition, Dr. Feldman may prescribe medicated eye drops and non-preserved artificial tears to reduce inflammation, promote healing and prevent dryness. It is important to follow the instructions provided by Dr. Sandy T. Feldman and her team and to attend all follow-up appointments to ensure the best possible results.

The vast majority of patients who have undergone the EVO ICL™ implantable collamer lens no longer rely on corrective lenses for their everyday activities. During the consultation prior to the EVO ICL™, Dr. Sandy T. Feldman and her associates will discuss with you whether this is likely to occur. If you have a prescription above 15 diopters of nearsightedness or greater than 4 diopters of astigmatism, glasses may be needed for certain activities, like driving at night.

According to a study published in the Journal of Cataract and Refractive Surgery, over 95% of patients who received the EVO ICL™ implant reported that they no longer needed glasses or contact lenses for their daily activities.1

It's important to note that there are some cases where glasses may still be needed after the EVO ICL™ surgery. For example, patients with an extremely high degree of nearsightedness or astigmatism may still need glasses for certain activities, such as driving at night. Additionally, some patients may experience minor residual refractive errors, which can be corrected with glasses or additional surgery if needed. The EVO ICL works in harmony with your natural vision. As such, it does not correct for presbyopia so patients who have vision correction with the EVO ICL may need reading glasses for near vision in their mid 40s and later.

During the consultation process at Clearview Eye and Laser Medical Center, Dr. Sandy T. Feldman and her team will discuss the expected outcomes and potential need for glasses following the EVO ICL™ procedure. It's important to follow all post-operative instructions to ensure the best possible results and minimize the need for corrective lenses.

  1. Sanders D, Sanders A, Dejaco-Ruhswurm I, et al. Five-year analysis of the safety and efficacy of the implantable collamer lens for the correction of myopia. J Cataract Refract Surg. 2018;44(11):1362-1370. doi:10.1016/j.jcrs.2018.08.036

This is a difficult question to answer as it depends on each individual patient's eyes, lifestyle and health. The most important question is which procedure is best for YOU. Both the EVO ICL™ and LASIK are very effective methods of vision correction surgery and have a high success rate of achieving spectacle independence.

It is important to note that EVO ICL™ and LASIK are different procedures that correct nearsightednes with or without astigmatism. LASIK corrects vision by reshaping the cornea, while EVO ICL™ involves implanting a lens in the eye. EVO ICL™ is often a better option for patients with very high prescriptions, thin corneas or dry eyes, whereas LASIK may be a better option for patients with moderate to high prescriptions and good corneal thickness.

While LASIK is a more well-known procedure and results of wavefront guided [iDesign LASIK] achieve 20/20 or better vision in more than 95% of patients1, the EVO ICL™ has been shown to have advantages over LASIK in certain cases. For example, a study published in the Journal of Refractive Surgery found that EVO ICL™ provided better visual acuity and contrast sensitivity in patients with high myopia compared to LASIK. Additionally, EVO ICL™ may be a better option for patients who are not suitable candidates for LASIK due to thin corneas or other factors.2

Both procedures have a high patient satisfaction rate, 96% for LASIK and 99.4% of the EVO ICL™.3-5

While LASIK is a more well-known procedure, EVO ICL™ has been shown to have advantages over LASIK in certain cases. For example, a study published found that EVO ICL™ provided better visual acuity and contrast sensitivity in patients with high myopia compared to LASIK.6 Additionally, EVO ICL™ may be a better option for patients who are not suitable candidates for LASIK due to thin corneas, higher prescriptions or other factors.

Ultimately, the decision between EVO ICL™ and LASIK should be based on a thorough consultation with a qualified ophthalmologist like Dr. Sandy T. Feldman. She has significant experience in most advanced forms of surgical vision correction available.

and can evaluate your eyes and discuss the advantages and disadvantages of each procedure in order to help you make an informed decision about the best way to achieve clear, sharp vision.

  1. Manche E, Lu L. A prospective randomized, fellow eye study comparing wavefront guided and topography guided LASIK surgery. Presentation ASCRS annual meeting 2023.
  2. Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481
  3. Staar Survey.
  4. “Is LASIK Safe? What You Need to Know.” Refractive Surgery Council, 13 Oct. 2022, https://americanrefractivesurgerycouncil.org/is-lasik-safe/.
  5. Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmol. 2017;135(1):13–22. doi:10.1001/jamaophthalmol.2016.4587. Available: https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2587831. Accessed March 1, 2021.
  6. Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual performance after implantable collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Ophthalmol. 2009 Jul;148(1):164-70.

There are always risks associated with any kind of surgery, and like LASIK, the EVO ICL™ is no exception. However, the EVO ICL™ implantable collamer lens procedure is considered a very safe procedure with a low risk of complications.10,16 Some potential risks associated with the EVO ICL™ include glare, halos or double vision, cataracts, increased intraocular pressure, loss of best corrected visual acuity as well as a need for a second surgery, risk of infection or inflammation.16 However, these risks are generally low and can be minimized with proper preoperative evaluation and postoperative care.

Comparatively, LASIK surgery also has a low risk of complications but the specific risks may differ. LASIK carries a slightly higher risk of post-operative dry eyes and the corneal flap created during the surgery may lead to complications, although such issues are rare.12,13,17,18

Ultimately, the choice of which procedure to undergo depends on each individual patient's eyes, lifestyle and health. It is important to have a thorough consultation with an experienced surgeon like Dr. Sandy T. Feldman at Clearview Eye and Laser Medical Center to determine which procedure is right for you and what risks, if any, may be involved for you.

17. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

18. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

The EVO ICL™ is the most advanced and latest version of the tried-and-true Visian ICL. The Visian ICL has been used for over 15 years and more than 400,000 procedures have been performed with great success. The EVO ICL builds on that success by further improving the design of the lens.

Although the EVO ICL™ has received FDA approval in 20221, the lens has been in use outside of the United States for more than 10 years, and over 2,000,000 ICL’s have been implanted worldwide. The EVO ICL™ builds on the success of the Visian ICL, which has been used for over 15 years and has had a high success rate with over 400,000 procedures performed.

The EVO ICL™ is made from a highly biocompatible material known as collamer, which is a proprietary material that provides excellent optical clarity and is well-tolerated by the eye. The EVO ICL™ has an innovative design that allows for better fitting and alignment within the eye, resulting in improved vision outcomes. Additionally, the EVO ICL™ has a central port that allows for better fluid flow, which reduces the risk of cataract formation and provides better long-term results.

In summary, while the EVO ICL™ is a new lens in the United States, it has been used successfully for over 10 years worldwide and builds upon the success of the Visian ICL. The advanced design of EVO ICL™ and use of highly biocompatible materials make it an excellent option for patients seeking vision correction surgery. To determine if the EVO ICL™ is right for you, it is important to consult with a highly experienced EVO ICL™ ophthalmologist, such as Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center.

  1. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035

The age range for EVO ICL™ is determined by the FDA based on clinical trials and studies. Patients who are between the ages of 21 and 45 are typically good candidates for this procedure because their eyes have finished developing, and their prescription has stabilized.16 However, age is not the only factor that is considered when determining whether someone is a good candidate for EVO ICL™. Other factors, such as the health of the patient's eyes and the severity of their refractive error, will also be taken into account.

It is worth noting that doctors may choose to implant lenses outside of the approved age range at their discretion, known as "off-label" use. This decision is generally made on a case-by-case basis and depends upon the patient's individual circumstances and eyes. It is important to discuss the risks and benefits of the EVO ICL™ procedure with your eye doctor, who can help determine if you are a good candidate for the procedure based on your unique situation. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center can help determine if the EVO ICL™ is right for you.

Yes, it is often possible, but not often necessary. If you have a small residual prescription or your vision changes over time, and your corneal thickness and eye health indicate it is safe, you may be able to have a second surgery like LASIK to fine-tune your vision. Fortunately, this is not commonly needed as the success rate with the EVO implantable collamer lens is quite high.

It is important to note that the decision to have LASIK after an EVO ICL™ implantation is dependent on individual circumstances and you should have a complete eye examination. In some cases, LASIK may not be the best option, and other options such as PRK may be considered instead. Additionally, the timing of a LASIK procedure after EVO ICL™ implantation is also an important factor to consider, as the eyes need time to fully heal and stabilize after the initial surgery.

Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center have extensive experience in both EVO ICL™ implantation and LASIK procedures. They can help determine whether LASIK is a viable option for your eyes, and provide guidance on the best timing for the procedure. It is important to follow post-operative instructions closely to ensure proper healing and minimize the risk of complications.

After undergoing the EVO ICL™ implantable collamer lens procedure, many patients experience an immediate improvement in their vision. It is common for patients to be able to read the clock across the room as soon as they sit up from the surgical bed! In fact, most individuals who have the EVO ICL™ procedure at Clearview Eye and Laser Medical Center in San Diego, California, report that their vision is quite good the day after surgery.

The full healing process and stabilization of vision may take some time. The speed at which vision fully stabilizes can vary from person to person. Some patients may notice continued improvements in their vision in the days and weeks following the procedure while others experience excellent vision within the first postoperative day.

It is quite normal to experience some fluctuations in vision during the initial healing period. Blurriness or fluctuating vision can occur as the eyes adjust and adapt to the presence of the implanted lens and the eye heals. However, these changes are typically temporary, and the majority of patients achieve stable and clear vision as the eyes continue to heal.

It is essential to follow the post-operative care instructions provided by Dr. Sandy T. Feldman and the team at Clearview Eye and Laser Medical Center to optimize the healing process and ensure the best possible visual outcomes.

The EVO ICLTM surgery is performed under topical anesthesia utilizing eye drops, which numbs the eye without causing any pain. An anesthesiologist will also give you medicine to help you relax. You may feel pressure during the surgery, but no pain.

During the EVO ICLTM implantable collamer lens procedure, patients typically experience minimal discomfort due to the use of topical anesthesia.1 The eye drops used for anesthesia effectively numb the eye, ensuring that the surgery is painless. Additionally, an anesthesiologist may administer medication to help you relax during the procedure.

While you may feel some pressure or sensation during the surgery, these feelings are not typically associated with pain. The surgeon and the surgical team will take utmost care to ensure your comfort throughout the procedure. Clearview Eye and Laser Medical Center, located in San Diego, California, is known for providing a patient-centered approach and ensuring a comfortable surgical experience.

The use of topical anesthesia and the absence of pain during the EVO ICLTM surgery contribute to the overall positive patient experience. The procedure is well-tolerated by most individuals, allowing them to remain relaxed and at ease during the treatment.

  1. "EVO Implantable Collamer Lens." www.discovericl.com.

The actual EVO ICL™ surgery is not painful, and patients typically do not feel the lens in their eye once it is placed. The use of anesthetic drops during the procedure effectively numbs the eye, ensuring a comfortable experience. After the surgery, some individuals may experience mild discomfort and sensitivity to light, but these symptoms typically resolve within a few days to weeks.

During the EVO ICL™ implantable collamer lens surgery, the administration of anesthetic drops plays a crucial role in minimizing any potential discomfort. These drops numb the eye, preventing pain or significant discomfort during the procedure. Patients at Clearview Eye and Laser Medical Center in San Diego, California, benefit from the expertise of Dr. Sandy T. Feldman and her team, who prioritize patient comfort and provide a comprehensive approach to pain management during and after the surgery.

Following your San Diego EVO ICL™ surgery, it is normal to experience some post-operative discomfort, such as mild irritation or a gritty sensation in the eyes. Any discomfort is typically temporary and subsides within a day or two days as the eyes heal. It is important to follow the post-operative instructions provided and use any prescribed medications or eye drops to aid in the healing process and alleviate discomfort.

Following the surgical procedure, the lens cannot be felt inside the eye and is only visible with the use of an ophthalmic microscope. Which means your eyes should feel like they normally do, but you will be able to see without the aid of glasses or contacts!

EVO ICL™ surgery is considered a safe procedure with a low risk of complications. While all surgeries carry some inherent risks, including rare but extreme possibilities, the likelihood of experiencing vision loss or going blind from EVO ICL™ surgery is extremely unlikely.

Extensive research and clinical data have demonstrated the safety and efficacy of the EVO ICL™ implantable collamer lens. With over 2 million successful ICL lens procedures performed worldwide, the risk of experiencing severe complications resulting in vision loss is minimal1. Side effects can occur and are detailed in the FDA patient information booklet.2,3

Dr. Sandy T. Feldman and her experienced team at Clearview Eye and Laser Medical Center in San Diego, California, have a deep understanding of the potential risks and take necessary precautions to ensure patient safety during the EVO ICL™ surgery.

During your complimentary consultation, Dr. Feldman will evaluate your individual circumstances, including your unique vision and eye health, to determine the potential risks associated with EVO ICL™ surgery.

This personalized approach allows for a thorough assessment of any potential risks and ensures that the procedure is tailored to your specific needs and safety considerations.

It is important to discuss any concerns or questions you may have about the risks associated with EVO ICL™ surgery with your surgeon. By choosing a reputable and experienced EVO ICL™ surgeon like Dr. Feldman, you can have confidence in the safety and success of the procedure.

References:

  1. "EVO Implantable Collamer Lens." www.discovericl.com.
  2. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035
  3. https://www.clearvieweyes.com/fdabooklets/

Celebrities from many different fields have chosen to undergo the EVO ICL™ surgery to correct their vision. While many celebrities prefer to keep their medical procedures private, a few have openly shared their positive experiences with the EVO ICL™ surgery.

Joe Jonas, a popular singer and member of the Jonas Brothers, has been endorsing the EVO ICL™ lens after achieving excellent vision through the procedure.

Actress Peyton List, known for her role in Cobra Kai, has also undergone the EVO ICL™ surgery and publicly shared her success story.

Additionally, India Gants, winner of America's Next Top Model, has spoken about her experience with the ICL™ surgery at the Staar Surgical Experience Opening.

https://www.tiktok.com/@indiagants/video/7136240967547358507?lang=en

https://finance.yahoo.com/news/staar-surgical-opens-evo-experience-120000918.html

NBA player Max Strus has undergone the EVO ICL™ procedure as well and has shared his journey with the lens.

Internationally, YooA, a member of the K-pop group Oh My Girl, has also undergone the EVO ICL™ procedure, contributing to its global recognition and popularity.

https://twitter.com/yooazones/status/1660571186752024576

https://forum.allkpop.com/thread/103789-oh-my-girl-yooa-for-evo-visian-icl/

The EVO ICL™ surgery has gained significant popularity worldwide, with a growing number of individuals choosing this life-changing procedure to improve their vision. It is estimated that over 2,000,000 people have already undergone the EVO ICL™ surgery1. This number continues to increase as the procedure becomes more widely known in the United States and accessible around the world.

The EVO ICL™ has been utilized outside of the United States for more than 10 years and has achieved remarkable success in improving visual acuity and quality of life for patients. With its FDA approval in the United States in 20222, the availability of the EVO ICL™ has expanded, and more people are opting for this advanced implantable collamer lens to correct refractive errors such as myopia, and astigmatism.

Clearview Eye and Laser Medical Center, located in San Diego, California, is at the forefront of providing EVO ICL™ surgeries and has helped numerous individuals achieve clearer and sharper vision.

  1. Staar Surgical Company. www.discovericl.com
  2. STAAR Surgical receives FDA approval for EVO ICL™ for myopia. https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035

When selecting a surgeon for your EVO ICL™ surgery, it is crucial to prioritize experience and expertise. Dr. Sandy T. Feldman, our renowned ophthalmologist at Clearview Eye and Laser Medical Center, is widely recognized as one of the most experienced ICL surgeons in the country, and she holds the distinction of being the #1 EVO ICL™ surgeon in San Diego1. Choosing a surgeon with a track record of successful EVO ICL™ surgeries can provide you with confidence and peace of mind throughout the process.

Clearview Eye and Laser Medical Center, located in San Diego, is an esteemed facility known for its exceptional eye care services. At Clearview Eye and Laser Medical Center, we also know that beyond the experience and talent of a surgeon, it is equally important to find a surgeon and clinical team who listens to you and is willing to work with you to achieve your goals for better vision.

Led by Dr. Sandy T. Feldman, Clearview is dedicated to providing personalized care and achieving optimal outcomes for each patient. Dr. Feldman and her clinical team prioritize open communication, actively listening to your concerns and goals for better vision. We work collaboratively with you to develop a customized treatment plan that aligns with your specific needs and desires.

  1. As reported by Staar Surgical, DiscoverICL.com, find a doctor based upon utilization in San Diego

When considering the choice between EVO ICL™ and SMILE (Small Incision Lenticule Extraction) for vision correction surgery, it is essential to understand that the best option depends on an individual’s eyes, lifestyle and other factors. Both procedures offer distinct advantages, and the suitability of each procedure varies from person to person. Having a consultation with Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center, is crucial in determining the most appropriate solution for your specific visual needs.

EVO ICL™ surgery is particularly beneficial for individuals with thin corneas or high degrees of nearsightedness and/or astigmatism. It too can be performed in nearsighted individuals who have a nearsighted prescription of 3 D or more. The EVO ICL™ procedure involves the placement of a clear implantable collamer lens in front of the eye's natural lens to correct vision. Because the EVO ICL™ procedure does not remove corneal tissue, it may be an alternative to LASIK eye surgery in individuals with high prescriptions or thinner corneas. The EVO ICL™ often offers excellent outcomes for those who may not be suitable candidates for other forms of vision correction surgery.1 There may still be reasons that prevent you from being an ideal candidate for EVO ICL™ and an in-depth evaluation is performed to best determine your candidacy.

On the other hand, SMILE is a minimally invasive procedure that utilizes the Zeiss VisuMax laser technology to reshape the cornea and correct nearsighted and astigmatic refractive errors. It can be a very effective option for individuals who participate in contact sports or who have dry eyes. SMILE utilizes a small opening to remove the thin disc of tissue created by the laser and allows for rapid wound healing due to the small size of the opening.

To determine the most appropriate procedure for you, Dr. Sandy T. Feldman and the clinical team will evaluate your eye health, visual needs, and other factors to provide a personalized recommendation. Their expertise in various advanced vision correction techniques, including EVO ICL™, SMILE, and LASIK, allows them to offer customized solutions tailored to each patient's unique circumstances.

  1. https://us.discovericl.com/blog/help-for-thin-corneas

The average cost of EVO ICL™ surgery in the United States can vary depending on several factors, including the geographical location, the specific clinic or surgical center, prescription of the eye and any additional services or benefits included in the package. On average, the cost of EVO ICL™ surgery ranges from $3800 to $5800 per eye. It is important to note that this cost is an estimate and without a complete examination the cost cannot be determined.

The overall cost of EVO ICL™ surgery typically includes the cost of the physical lens itself, the surgeon's fee, facility fees, pre-operative and post-operative care, and any necessary follow-up visits. This comprehensive approach ensures that patients receive the highest level of care and support throughout the entire process. Sometimes, individuals’ prescriptions are so high that laser vision correction is needed after the EVO ICL™ and this too can influence the price.

Clearview Eye and Laser Medical Center, located in San Diego, California, is a renowned center that desires to make EVO ICL™ surgery affordable for its patients. By consulting with their experienced team, patients can receive a personalized assessment of their vision needs and a detailed breakdown of the associated costs.

Financing options are often available to make the cost of EVO ICL™ surgery more manageable. These options allow patients to pay for the procedure in affordable monthly installments, with costs averaging around $200 per month, depending on the financing plan and terms. Through care credit, we also offer no interest plans which allow payment to be made over 24 months or with fixed interested over longer periods of time.

While the higher fixed cost of EVO ICL™ surgery is sometimes shocking to patients. When considering the cost of glasses with higher optical density so they are thinner, antireflective coating, the need for sunglasses, contact lenses and the cases and solutions, individuals will usually exhibit a cost savings over time. The most important factor is the feeling that one obtains when they wake up and realize they can see!

At Clearview Eye and Laser Medical Center in San Diego, CA, we offers free in-depth evaluations at no cost to determine what vision correction procedure is right for you. At that evaluation an accurate, breakdown of all costs will be provided to help you decide if and when you would like to move forward with vision correction surgery.

The EVO ICL™ lenses do not block sunlight as they are clear. However, these lenses offer an additional benefit of blocking the UV rays. UV rays are harmful to the eyes and can contribute to various eye conditions, including cataracts and macular degeneration. The EVO ICL™ lenses, while transparent, have the ability to filter out a significant portion of the harmful UV rays from reaching the eye, providing some level of protection against UV damage.

By having the EVO ICL™ lenses in your eyes, individuals can enjoy clearer vision without compromising their eye's exposure to UV radiation. This is particularly important in sunny locations like California, where residents often experience prolonged sun exposure. The inherent UV-blocking feature of the EVO ICL™ lenses adds an extra layer of protection to safeguard the eyes from potential UV-related harm.

Please note that while the EVO ICL™ lenses offer some UV protection, we still advise that patients wear sunglasses with proper UV filters when exposed to intense sunlight for extended periods, as they provide comprehensive protection for the eye as well as eyelids.

EVO ICL™ surgery boasts a high success rate. However, if complications arise, the lens may need to be repositioned or removed. In rare cases, more serious side effects such as reduced endothelial cell count, glaucoma, or retinal detachments could occur. It's crucial to discuss potential risks thoroughly with Dr. Sandy T. Feldman during your consultation. For comprehensive safety and efficacy details, refer to the FDA's patient information booklet on EVO ICL™, available here.

The EVO ICL™ surgery typically lasts about 10 to 20 minutes per eye. However, patients should expect to spend approximately 2 to 3 hours at the surgical center on the day of the surgery to accommodate pre-operative preparation and post-operative care.

An Intraocular Lens (IOL) is implanted inside the eye to replace a dysfunctional or cataractous natural lens. In contrast, an EVO ICL™ is a supplementary lens placed in front of the eye’s natural lens. It works in conjunction with the natural lens to correct vision without removing or replacing the eye's original structures.

When considering EVO ICL™ surgery, other refractive options such as LASIK, modern Photorefractive Keratectomy (PRK), SMILE LASIK, and custom laser refractive lens replacement might be discussed. The most suitable procedure depends on your specific vision needs, corneal health, and lifestyle. Dr. Sandy Feldman can help determine the best approach based on a comprehensive evaluation of your eyes.

No, the EVO ICL™ procedure does not change the color of your eyes. The lens is clear and placed behind the iris, the colored part of the eye, so it does not alter the appearance of your eye color.

These responses are crafted to provide a clear, detailed understanding of each aspect, emphasizing safety, procedural details, and the distinctions between different vision correction options.

The EVO ICL™, or Implantable Collamer Lens, is a remarkable advancement in vision correction technology known for its compact size and customizable features. When considering the size of the EVO ICL™ lens, it's important to understand that these small lenses are tailored to the specific dimensions of an individual's eye. Here are some details regarding the size of the EVO ICL™ lens:

  • Custom Sizing: EVO ICL™ lenses come in multiple sizes to ensure a custom-fit for each patient. The lenses are specifically ordered for your eyes to accommodate differences in your eye anatomy, such as the anterior chamber depth, pupil size, the curvature of the cornea, and of course, the prescription of your eye. This customization ensures a secure and comfortable fit within the eye. At the current time, the EVO ICL™ comes in four different sizes in the US (12.1, 12.6, 13.2, and 13.7).
  • Compact Design: The EVO ICL™ lenses are notably compact. The total length of the lens is approximately 13.0 mm, making it smaller than a button. The optic portion of the lens, which is the part responsible for correcting your vision, typically ranges from 5 to 6 mm in diameter, that’s right millimeters in size.
  • Minimal Interference: The small size of the EVO ICL™ allows it to be discreetly positioned within the eye. Its placement behind the iris ensures optimal visual clarity, positioned just in front of the eye’s natural lens. It remains virtually invisible to both the patient and observers.
  • Personalized Fit: The customization of the lens size is crucial for optimizing vision correction while minimizing the risk of complications. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego use precise measurements to determine the most appropriate lens size and prescription for each patient.

The small, individualized design of EVO ICL™ is a testament to its effectiveness and safety. It offers vision correction without impacting the eye's aesthetics. If you are considering EVO ICL™ surgery, we recommend a thorough consultation to determine whether you are a good candidate and the best lens for your eyes.

The EVO ICL™ (Implantable Collamer Lens) is renowned for its biocompatible material of collagen, which significantly reduces the risk of rejection by the body. The lens is made from a material that harmonizes with the eye's natural biology, ensuring it remains well-tolerated and effective. Here's a closer look at why your body will not reject the EVO ICL™ lens:

  • Biocompatible Material: The EVO ICL™ is composed of a biocompatible material. This collamer is derived from collagen, a naturally occurring protein found in various parts of the human body, including the eye. This biocompatibility minimizes or eliminates the chance of an adverse immune response or rejection.
  • Collagen in the Eye: Collagen is a fundamental component of the eye's structure. It is present in the cornea, which is essential for maintaining the eye's shape and clarity. The collagen-based EVO ICL™ integrates seamlessly with the eye's existing collagen-rich environment.
  • Safe and Well-Tolerated: Clinical studies and patient experiences have shown that the EVO ICL™ is safe and well-tolerated. Its biocompatible nature ensures it doesn't trigger allergic reactions or adverse immune responses. Two million EVO ICL™ has been inserted in patients for over 10 years outside of the U.S. in at least 63 countries. The growth of this procedure worldwide points to its success and satisfaction by patients.
  • Removable: The EVO ICL™ can be removed should it ever be needed. Note that It is not common that it needs to be removed.
  • FDA Approval: The EVO ICL™ has received approval from the U.S. Food and Drug Administration (FDA) following rigorous testing and evaluation, attesting to its safety and efficacy. It has also been used outside of the US for more than 10 years.

Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego, California, are experienced in EVO ICL™ implantation. They provide thorough consultations to ensure that the lens is a suitable option for each patient's unique visual needs and ocular health.

In summary, the EVO ICL™'s biocompatible material, combined with its FDA approval, and use for a decade outside of the US prior to FDA approval, makes it highly unlikely for the lens to be rejected by the body. Patients can have confidence in the safety and efficacy of this advanced vision correction solution.

References:

  • U.S. Food and Drug Administration. (2022). EVO (EVO Visian Implantable Collamer Lens). Retrieved from https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035.

Following EVO ICL™ surgery, a carefully prescribed regimen of eye drops is essential to support the healing process and minimize the risk of complications. Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego, California, will provide clear instructions regarding post-operative medications, emphasizing the importance of adherence to the recommended regimens. Here's a detailed overview of the medications you can expect and the recommended duration for their use:

  • Antibiotics: You will receive a prescription for antibiotic eye drops, which are crucial for preventing infection in the post-operative period. It's imperative to use these antibiotics precisely as directed, generally four times daily. Typically, you will continue taking the antibiotics for one week following surgery to safeguard against any potential infection.
  • Anti-Inflammatory Eye Drops: Anti-inflammatory eye drops are another vital component of your post-operative medication regimen. These drops help reduce inflammation and enhance the healing process. Dr. Feldman and her team will provide precise instructions on how to use these eye drops. Typically, you'll continue using them for approximately two weeks after surgery.
  • Additional Eye Drops: Depending on your specific needs and ocular health, additional eye drops may be recommended for you. These could include lubricating or artificial tear drops to maintain eye moisture and comfort during the recovery phase.

Compliance with the prescribed medications and their specified duration is essential to ensure a successful recovery and optimize the outcomes of your EVO ICL™ surgery. Dr. Sandy T. Feldman's extensive experience in vision correction surgery, including the EVO ICL™, ensures that you receive comprehensive guidance and support throughout your recovery journey. We are only a phone call away for any questions.

The EVO ICL™ surgery primarily addresses refractive errors like myopia (nearsightedness) and astigmatism. It is not specifically designed to correct reading vision, nor does it adversely impact your ability to read. The procedure involves implanting a clear lens in front of the eye's natural lens to enhance your distance and possibly intermediate vision. However, the EVO ICL™ does not directly address presbyopia, a condition associated with the age-related loss of near vision.

If you have maintained good near vision while using contact lenses, you can generally expect to preserve that same near vision after EVO ICL™ lens implantation until you reach an age when natural near vision decline occurs, usually around 45 years and older. At that point, presbyopia makes reading small print more challenging.

For individuals over 45 who wish to correct their reading vision, alternative options like monovision (which can be done with EVO ICL™ vision correction) or Refractive Lens Exchange (RLE) surgery may be considered. Monovision or “blended vision” involves correcting one eye for distance and one for near vision, enabling better near vision without glasses. RLE surgery replaces the natural lens with a multifocal or accommodating intraocular lens to enhance both near and distance vision.

During your vision correction consultation with Dr. Sandy T. Feldman and her team at ClearView Eye and Laser Medical Center in San Diego, California, we will educate you about these alternatives and determine the most suitable approach to address your specific vision needs and lifestyle.

Undergoing EVO ICL™ surgery can significantly improve your vision and, in the vast majority of cases, allow you to legally drive without glasses or contact lenses. The EVO ICL™ is sometimes performed on extreme prescriptions in which the prescription is reduced. These individuals may often undergo laser vision correction to correct their vision to be able to drive without glasses.

To meet the visual requirements for driving without correction, you typically need to achieve 20/40 vision or better in both eyes. Once you attain this level of visual acuity after EVO ICLTM surgery and feel comfortable with your vision, you can pursue changing the designation on your driver's license.

After surgery and a visual assessment, Dr. Sandy T. Feldman and her team at Clearview Eye and Laser Medical Center in San Diego, California, will assist you in filling out the necessary forms for changing your license designation, which you can then submit to the Department of Motor Vehicles (DMV). This process ensures that you comply with legal vision standards for driving without glasses or contact lenses.

The likelihood of achieving driving vision without correction after EVO ICL™ surgery is high, with success rates ranging from 96.7% to 100% for individuals with preoperative prescriptions of -15.0 D (diopters) and below. This demonstrates the effectiveness of EVO ICL™ in providing clear and functional vision for daily activities, including driving.

In summary, it is very highly likely that EVO ICL™ surgery can enable you to meet the legal vision requirements for driving without corrective lenses, offering greater convenience and visual freedom.

EVO ICL™ surgery is not designed for treating individuals whose natural lenses are cloudy or cataractous. Instead, it is a highly effective vision correction procedure primarily intended for patients with a healthy natural lens who deal with nearsightedness or those who have nearsightedness with astigmatism from a low of -3D of nearsightedness to a high of -20 D of nearsightedness. The EVO ICL™ is a valuable option for individuals seeking clear, glasses-free vision.

In contrast to EVO ICL™ surgery, cataract surgery serves an entirely different purpose. During cataract surgery, the clouded natural lens within the eye, known as a cataract, is removed and replaced with an advanced intraocular lens implant. These intraocular lens implants are tailored to restore clear vision after cataract removal. They come in various types to address different visual needs, including light adjustable, multifocal or extended depth of focus and toric or astigmatic lenses.

Dr. Sandy T. Feldman at Clearview Eye and Laser Medical Center in San Diego is proficient in a wide range of eye surgeries, including EVO ICL™, modern laser cataract surgery, and refractive lens replacement. Her expertise also extends to procedures like LASIK, SMILE, and PRK. With this broad knowledge and experience, Dr. Feldman can guide patients toward the most suitable vision correction method based on their individual eye health, visual requirements, and preferences.

In short, the EVO ICL™ surgery is specifically designed for vision correction, and it does not address cataracts. A different procedure is needed to address vision correction for people who have developed cataracts. The decision between these procedures should be made in consultation with a qualified eye surgeon who can assess your unique visual needs and offer guidance on the most appropriate treatment option.

Certainly, it's possible for individuals to undergo different types of vision correction surgeries in each eye when their refractive error varies between eyes just as it is also possible to need a combination of multiple types of surgery in rare cases. This personalized approach to vision correction aims to optimize visual acuity in each eye while minimizing the reliance on glasses or contact lenses.

For instance, if one eye has a lower degree of myopia (nearsightedness) like -2 diopters, LASIK (Laser-Assisted In Situ Keratomileusis) or SMILE (Small Incision Lenticule Extraction) surgery might be suitable. These procedures reshape the cornea to correct refractive errors and typically work well for mild to moderate myopia.

In contrast, if the other eye has a higher degree of myopia, say -5 diopters or more, EVO ICL™ surgery can be a better choice. EVO ICL™ (Implantable Collamer Lens) is particularly effective for individuals with more severe nearsightedness, as it involves implanting a clear lens in front of the eye's natural lens to correct vision.

Dr. Sandy T. Feldman, based in San Diego at the Clearview Eye & Laser Medical Center, is a leading expert in various vision correction procedures, including LASIK, SMILE, and EVO ICL™ surgery. She can assess your unique visual needs and recommend a customized treatment plan that may involve different techniques for each eye. This approach ensures that you achieve the best possible visual outcomes.

In summary, combining LASIK or SMILE with EVO ICLT™ surgery in different eyes is a practical solution for individuals with varying degrees of myopia, allowing them to achieve excellent visual results tailored to their specific needs.

Undergoing EVO ICL™ (Implantable Collamer Lens) surgery and pursuing a career that involves flying or military service are not mutually exclusive. The EVO ICL™ procedure offers remarkable vision correction results, making it a viable option for individuals who meet the visual requirements for such professions.

In the context of aviation, the EVO ICL™ has demonstrated its effectiveness in improving vision. Provided that candidates undergo the necessary visual assessments and meet the specified requirements, they can indeed pursue careers as pilots or in aviation-related roles. The results of the EVO ICL™ surgery have been substantial, contributing to its acceptance in aviation circles.

Similarly, individuals aspiring to serve in the military can also consider EVO ICL™ surgery. In a U.S. Army Study, 98% of participants reported improved vision, and 75% reported better vision post-surgery than with their contact lenses before the procedure. Moreover, the ICL exhibited stability even in challenging situations, as evidenced by a case where the lens did not dislocate or move in a soldier who experienced a grenade blast.

If you are contemplating EVO ICL™ surgery and are associated with the military, it's advisable to consult with your commanding officer and adhere to established protocols and guidelines regarding the procedure. While the EVO ICL™ offers the potential for significant vision enhancement, ensuring that it aligns with military regulations is crucial for a seamless transition.

EVO ICL™ surgery can open doors to diverse career paths, including aviation and military service, as long as candidates fulfill the requisite visual criteria and adhere to the relevant protocols.

Kyle T Packer 1, Anton Vlasov, David L Greenburg, et al. U.S. military implantable collamer lens surgical outcomes:

11-year retrospective review

J Cataract Refract Surg. 2022 Jun 1;48(6):649-656.

EVO ICL™ (Implantable Collamer Lens) surgery has emerged as a highly effective vision correction procedure with a strong track record of patient satisfaction. One common concern among prospective patients is whether these lenses cause halo or glare at night, which can affect night vision and overall visual comfort.

In general, EVO ICL™ lenses are designed to minimize the occurrence of significant halo or glare. These lenses are engineered with precision and utilize advanced biocompatible materials that work in harmony with the eye's natural structures. This design helps reduce the likelihood of visual disturbances.

However, it's essential to consider the role of pupil size. At night or in dimly lit environments, the pupils naturally dilate to allow more light into the eye. This dilation can occasionally lead to the perception of glare and halos around light sources, such as oncoming headlights while driving.

It's worth noting that while most individuals experience little to no nighttime visual disturbances with EVO ICL™ lenses, there can be exceptions. For example, the FDA study mentions a case where a patient reported bothersome glare and halos. In this specific instance, the lens was removed, resulting in the elimination of the glare and halo.

Patients considering EVO ICL™ surgery should discuss their unique visual needs, lifestyle, and any concerns related to nighttime visual disturbances to Dr. Sandy T. Feldman and her associates at Clearview Eye and Laser Medical Center in San Diego. This proactive approach ensures that potential risks and benefits are thoroughly evaluated.

In summary, EVO ICL™ lenses are designed to provide excellent visual outcomes, including minimal halo or glare during. However, some individuals may experience these phenomena when their pupils dilate at night. Usually, over time as the eye heals, glare and halo are not bothersome and do not generally limit one’s night time activities.

During the consultation and evaluation of your eye and discussion with you will help Dr. Sandy T. Feldman determines the most suitable vision correction option and manages any potential visual disturbances, offering you the best possible visual experience.

https://www.fda.gov/medical-devices/recently-approved-devices/evoevo-visian-implantable-collamer-lens-p030016s035.

https://crstodayeurope.com/articles/highlights-from-the-evo-visian-icl-experts-meeting-2016/enhancing-night-vision-with-the-evo-visian-icl/

The EVO ICL™, or Implantable Collamer Lens, represents a significant advancement in vision correction technology. Developed as the newest iteration of the implantable collamer lens, this innovative solution offers several improvements over its predecessors. Notably, the design of the EVO ICL™ incorporates a feature that sets it apart: the inclusion of small micro-channels within the lens. These fenestrations serve a crucial purpose in enhancing the overall surgical experience and visual outcomes for patients.

One of the standout advantages of the micro-channel design is the facilitation of fluid flow. These channels permit the passage of aqueous humor, the clear fluid inside the eye, through the lens. This is a notable improvement over previous versions of the Visian implantable collamer lens, where an additional surgical step was required to create a hole in the lens to allow for fluid flow. The incorporation of these fenestrations streamlines the surgical process and eliminates the need for this step, resulting in a more efficient and less invasive procedure.

Furthermore, these micro-channels contribute to the long-term health of the eye. By allowing natural fluids to pass through, they help maintain proper intraocular pressure and prevent potential complications associated with fluid accumulation behind the lens.

The EVO ICL™ is designed to provide excellent vision correction for patients with myopia (nearsightedness), and myopia with astigmatism. By optimizing the surgical process and ensuring the lens functions seamlessly within the eye, it offers a solution that not only enhances visual acuity but also prioritizes the patient's safety and comfort.

With these advancements, the EVO ICL™ has further solidified its position as a state of the art option in the realm of vision correction. Patients considering this procedure can benefit from the latest technological innovations in ophthalmology, which are designed to improve their quality of life and reduce or eliminate the dependence on traditional visual aids like glasses and/or contact lenses.

Get Started with LASIK

Schedule your free LASIK exam with Dr. Sandy T. Feldman and see how LASIK can change your life.

Choose Appointment Time?

Copyright © 2024 Clearview Eye and Laser Medical Center in San Diego, California. All rights reserved.

Privacy Policy

LASIK is a medical procedure with risks involved and isn't right for everyone. Individual results may vary. Talk to your eye doctor and consider both the risks and benefits before having the procedure. Additional information can be found at our website or at fda.gov. the material contained on this site is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider.

Schedule Your Free LASIK Consultation